PharmaJet and Mundipharma partner to expand access to needle-free technology in emerging markets
GOLDEN, Colo. – Feb. 14, 2017 – PharmaJet® Inc., the maker of needle-free injection technology, today announced that needle-free delivery with the PharmaJet Stratis® Injector is now available for both a trivalent and quadrivalent influenza vaccine for the 2017-18 influenza season.
“The addition of a quadrivalent influenza vaccine gives healthcare providers a wider choice of vaccines that they can deliver without a needle,” said Ron Lowy, PharmaJet Chairman and CEO. “PharmaJet offers the only needle-free delivery system approved by the FDA for administration of inactivated influenza vaccines. Expanding the vaccine selection that can be used with our device is another significant step toward improving public health through expanded immunization coverage, as well as improved safety of caregivers.”
Refer to Instructions for Use to ensure safe injections and to review risks.
Related posts